leadf
logo-loader
LSE:KNB

Kanabo Group PLC

Receive alerts
Market:
LSE
Market Cap:
£65.51 m
Price
17.75 GBX
Change
0.00%
52 weeks high
29.00
52 weeks low
13.53

In brief

Kanabo is creating a new standard in the medical cannabis industry by improving the well-being of millions around the world. We focus on the distribution of Cannabis-derived products for medical patients, and non-THC products for CBD consumers. We have conducted extensive R&D in order to develop high-quality Cannabis extract formulas, innovative medical-grade vaporizers, and various non-smoking consumption solutions – making use easy and accessible for anyone in need of treatment. Clinical and validation activities, including safety and efficiency tests, are conducted in Israel – an established leader in the Cannabis industry.

The company is selling initial products in Europe already, and is ready to scale up to meet market demands and projected sales and revenues.